Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
International Journal of Obesity (2005)
|
February 20, 2014
DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance
M C García-Cardona, F Huang, J M García-Vivas, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 11, 2015
Structure-based design of low-nanomolar PIM kinase inhibitors
Alexey Ishchenko, Lin Zhang, Jean-Yves Le Brazidec, et al.
Obesity Surgery
|
June 8, 2020
Recommendations to Manage Patients for Bariatric Surgery in the COVID-19 Pandemic: Experience from China
Zhiyong Dong, Peng Zhang, Jiangfan Zhu, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2012
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 30, 2011
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)
Lin Zhang, Junhua Fan, Jer-Hong Chong, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
International Journal of Obesity (2005)
|
February 20, 2014
DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance
M C García-Cardona, F Huang, J M García-Vivas, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 11, 2015
Structure-based design of low-nanomolar PIM kinase inhibitors
Alexey Ishchenko, Lin Zhang, Jean-Yves Le Brazidec, et al.
Obesity Surgery
|
June 8, 2020
Recommendations to Manage Patients for Bariatric Surgery in the COVID-19 Pandemic: Experience from China
Zhiyong Dong, Peng Zhang, Jiangfan Zhu, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2012
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors
Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 30, 2011
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)
Lin Zhang, Junhua Fan, Jer-Hong Chong, et al.
Page
of 6